Free EHR, EHR and Healthcare IT Newsletter Want to receive the latest updates on EHR, EMR and Healthcare IT news sent straight to your email? Get all the latest EHR News for FREE!

Veritas Capital and Elliott Management to Acquire Athenahealth for $5.7 billion

Evergreen Coast Capital to be Minority Investor in Combination of athenahealth and Veritas-Backed Virence

WATERTOWN, Mass., SEATTLE and NEW YORK, Nov. 12, 2018 /PRNewswire/ — athenahealth, Inc. (NASDAQ: ATHN), a leading provider of network-enabled services for hospital and ambulatory customers nationwide, Veritas Capital (“Veritas”) and Evergreen Coast Capital (“Evergreen”), today announced that they have entered into a definitive agreement under which an affiliate of Veritas and Evergreen will acquire athenahealth for approximately $5.7 billion in cash.

Under the terms of the agreement, athenahealth shareholders will receive $135 in cash per share. The per share purchase price represents a premium of approximately 12 percent over the company’s closing stock price on November 9, 2018, the last trading day prior to today’s announcement, and a premium of approximately 27 percent over the company’s closing stock price on May 17, 2017, the day prior to Elliott Management Corporation’s announcement that it had acquired an approximate 9 percent interest in the company.

Following the closing, Veritas and Evergreen expect to combine athenahealth with Virence Health (“Virence”), the GE Healthcare Value-based Care assets that Veritas acquired earlier this year. The combined business is expected to be a leading, privately-held healthcare information technology company with an extensive national provider network of customers and world-class products and solutions to help them thrive in an increasingly complex environment.

Following the close of that transaction, the combined company is expected to operate under the athenahealth brand and be headquartered in Watertown, Massachusetts. The company will be led by Virence Chairman and Chief Executive Officer Bob Segert and an executive leadership team comprised of executives from both companies. Following the completion of the transaction, Virence’s Workforce Management business will become a separate Veritas portfolio company under the API Healthcare brand.

“After a thorough strategic review process, we have decided to enter this agreement with Veritas, which we believe maximizes value for our shareholders and accelerates our goal to transform healthcare,” said Jeff Immelt, Executive Chairman of athenahealth. “Combining with Virence will create new opportunities for collaboration and growth. Operating as a private company with Veritas’s ownership and support will provide athenahealth with increased flexibility to achieve our purpose of unleashing our collective potential to transform healthcare.”

“athenahealth is a market leader and a natural and strategic fit with Virence,” said Ramzi Musallam, CEO and Managing Partner of Veritas Capital. “Virence and athenahealth have differentiated and complementary solutions, deep relationships with their respective customer bases and a shared culture of commitment to innovation. We look forward to leveraging our expertise in the sector, as well as the capabilities and solutions across both companies to provide superior value to customers, and create exciting growth opportunities for both sets of employees as Bob and the team build the future of healthcare IT.”

Veritas, a government and technology focused investor, has a proven track record of driving growth for companies within the healthcare technology space, as illustrated by the firm’s acquisition of Verscend Technologies and its combination with Cotiviti Holdings, as well as the firm’s investment in Truven Health Analytics. Veritas has a deep understanding of the urgent need to digitize the healthcare system and brings a culture of intense customer focus and a drive for growth through focused R&D and product innovation.

“We are excited by the opportunity to partner with athenahealth, one of the largest and most connected provider networks in the nation, to drive outcomes that matter the most to our customers,” said Bob Segert, Chairman and CEO of Virence. “athenahealth and Virence have complementary portfolios and highly-talented people, and this combination expands our depth and reach across the continuum of care. I’m looking forward to combining our mission-driven cultures to create an even stronger healthcare IT company.”

athenahealth investor Elliott Management Corporation (“Elliott”) has expressed support for the transaction. Elliott Partner Jesse Cohn said, “We are pleased to support this transformative transaction combining athenahealth and Virence, which we believe represents an outstanding, value-maximizing outcome for athenahealth shareholders.”

Upon completion of the transaction, Elliott’s private equity subsidiary, Evergreen Coast Capital, will retain a minority investment stake in the combined company.

Evergreen Managing Director Isaac Kim said, “We look forward to taking part in this unique opportunity. Under Bob’s leadership and with Veritas’ strategic oversight and strong track record of value creation, we believe the combined company will be a true leader in healthcare IT, ideally positioned to improve outcomes and reduce the cost of care.”

Approvals and Timing
The transaction is expected to close in the first quarter of 2019, subject to the approval of the holders of a majority of athenahealth’s outstanding shares and the satisfaction of customary closing conditions and regulatory approvals.

The athenahealth Board of Directors has unanimously approved the merger agreement and intends to recommend that athenahealth shareholders vote in favor of it at a Special Meeting of Stockholders, to be scheduled as soon as practicable.

The transaction is not subject to a financing condition.

Cancellation of Q3 2018 Earnings Call
In light of today’s announcement and the pending transaction, athenahealth will no longer be hosting its previously announced Q3 2018 earnings call today.

Advisors
Lazard and Centerview Partners are serving as financial advisors, and Weil, Gotshal & Manges LLP is serving as legal counsel to athenahealth.

Schulte, Roth & Zabel, LLP is acting as legal counsel to Veritas.

Deutsche Bank and RBC Capital Markets are acting as financial advisors to Evergreen, and Gibson, Dunn & Crutcher LLP is acting as legal advisor.

About athenahealth, Inc.
athenahealth partners with hospital and ambulatory customers to drive clinical and financial results. We offer medical record, revenue cycle, patient engagement, care coordination, and population health services. We combine insights from our network of more than 120,000 providers and approximately 117 million patients with deep industry knowledge and perform administrative work at scale. For more information, please visit www.athenahealth.com.

About Virence Health
Virence Health Technologies is a leading software provider that leverages technology and analytics to help healthcare providers across the continuum of care effectively manage their financial, clinical, and human capital workflows. Offering a comprehensive suite of innovative technology-enabled solutions, Virence aims to improve quality, increase efficiency, and reduce waste in the healthcare industry. Learn more at www.virencehealth.com.

About Veritas Capital
Veritas Capital is a leading private equity firm that invests in companies that provide critical products and services, primarily technology and technology-enabled solutions, to government and commercial customers worldwide, including those operating in the aerospace & defense, healthcare, technology, national security, communications, energy, government services and education industries. Veritas seeks to create value by strategically transforming the companies in which it invests through organic and inorganic means. For more information on Veritas Capital and its current and past investments, visit www.veritascapital.com.

About Elliott and Evergreen
Elliott Management Corporation manages two multi-strategy investment funds which combined have approximately $35 billion of assets under management. Its flagship fund, Elliott Associates, L.P., was founded in 1977, making it one of the oldest funds of its kind under continuous management. The Elliott funds’ investors include pension plans, sovereign wealth funds, endowments, foundations, funds-of-funds, high net worth individuals and families, and employees of the firm. This investment is being led by Evergreen Coast Capital, Elliott’s Menlo Park affiliate, which focuses on technology investing.

November 12, 2018 I Written By

John Lynn is the Founder of the HealthcareScene.com blog network which currently consists of 5 blogs containing over 11,000 articles with John having written over 5500 of the articles himself. These EMR and Healthcare IT related articles have been viewed over 18 million times. John also manages Healthcare IT Central and Healthcare IT Today, the leading career Health IT job board and blog. John is co-founder of InfluentialNetworks.com and Physia.com. John is highly involved in social media, and in addition to his blogs can also be found on Twitter: @techguy and @ehrandhit and LinkedIn.

Mobile Telehealth Company Medici Acquires DocbookMD

Global Telehealth Platform Adds Respected Doctor-Messaging Technology

Austin, Texas (November 6) – Medici today announced its acquisition of secure healthcare messaging company DocbookMD at the Exponential Medicine conference in San Diego, California. The acquisition will offer doctors and other healthcare providers access to a broad range of mobile communication and telehealth tools that will fundamentally change how doctors practice medicine. In the arrangement, Medici will assume DocbookMD’s technical assets, people and customer contracts including those with state medical associations.

Austin-based DocbookMD was founded in 2008 as an early collaboration tool and offers a secure text messaging application that allows medical professionals to communicate with one another. The DocbookMD application is endorsed by more than 42 state medical associations and 400 county medical associations. The mobile application supports more than 25,000 active doctors. Medici acquires DocbookMD from Scrypts, Inc. and financial terms of the acquisition were not disclosed.

Medici, also headquartered in Austin, provides a global HIPAA-compliant mobile app with secure text, voice and video messaging and allows doctors to provide virtual healthcare to patients. In addition to offering colleague-communication capabilities, the platform offers more than a dozen innovative features including in-app billing, e-prescribe prescriptions and e-refer referrals. Medici empowers doctors, veterinarians, psychologists and other healthcare providers to provide patient care from anywhere.

Medici plans to provide continued technology support for DocbookMD. Existing users and partners should expect uninterrupted usage of data, functionality and connectivity. Medici CEO & Founder, Clinton Phillips stated, “We are delighted to be acquiring one of the most trusted resources for doctors. Medici and DocbookMD are so well-aligned with each other, and with the interests of medical associations in helping doctors live and practice at the highest level.”

Original DocbookMD co-founder, Tracey Haas, DO, MPH, is supportive of the move, stating: “We are thrilled to see DocbookMD find a home at Medici, with its physician-centric technology that continues to push mobile health beyond secure messaging. We are excited to see how Medici and DocbookMD can help healthcare professionals better meet patient needs in this new era of medicine.”

Medici News Announcement at Exponential Medicine Conference

The Medici acquisition of DocbookMD is the company’s first major acquisition following a recent $22 million private capitalization round. https://www.prnewswire.com/news-releases/medici-announces-private-capital-raise-of-over-22-million-300666007.html

CEO & Founder Phillips was expected to speak at an innovation roundtable at Exponential Medicine (known as X-Med) this week in San Diego. The company did not disclose if additional M&A activity would be forthcoming. However, also last week, Medici announced the addition of Anne Jude Hunt, Ph.D., as vice president and head of product. Dr. Hunt comes to Medici from San Francisco with strong Artificial Intelligence (AI) and semantic sciences expertise.

“Exponential Medicine is the place where innovators come to make partnerships, build relationships, and break news,” said Dr. Daniel Kraft, Chair for Medicine & Neuroscience, Singularity University, Founder & Chair, Exponential Medicine. “We are living in a fast-moving, exponential age where the convergence of rapidly developing technologies is enabling vast new capabilities that can radically improve and disrupt the future of health, prevention, and clinical practice.”

“As a fan of Medici,” he added, “I am very pleased the leaders have chosen Exponential Medicine as the venue to announce its latest acquisition to bring more doctors on to its Medici telemedicine platform to care for the greatest number of patients.”

About Medici
Medici (https://medici.md) is addressing the future of healthcare by enabling patients to text, voice or video chat with their personal doctors, therapists, veterinarians and more. Considered the ‘WhatsApp of Healthcare, Medici is an effortless and secure communication tool that allows doctors to unchain themselves from their medical offices while taking great care of patients. Headquartered in Austin, Texas — Medici has offices in Johannesburg, South Africa and Washington, DC.

November 6, 2018 I Written By

John Lynn is the Founder of the HealthcareScene.com blog network which currently consists of 5 blogs containing over 11,000 articles with John having written over 5500 of the articles himself. These EMR and Healthcare IT related articles have been viewed over 18 million times. John also manages Healthcare IT Central and Healthcare IT Today, the leading career Health IT job board and blog. John is co-founder of InfluentialNetworks.com and Physia.com. John is highly involved in social media, and in addition to his blogs can also be found on Twitter: @techguy and @ehrandhit and LinkedIn.

Health Catalyst Acquires Medicity, Extending Its Leadership as the Data Platform for Healthcare

SALT LAKE CITY, July 11, 2018 – Health Catalyst, a leader in next-generation data, analytics,  and decision support, today announced completion of its acquisition of Medicity, one of the nation’s largest population health management companies with solutions for health information exchange (HIE), business intelligence, and provider and patient engagement.

Medicity adds to the Health Catalyst customer base more than 100 clients including 21 state and regional HIEs, large employers, health plans, 75 health systems encompassing over 1,000 hospitals and more than 185,000 providers in physician groups and extended care facilities, in support of over 75 million patients. The combined company is positioned to solve many of the most pressing problems of large healthcare delivery networks as they seek to improve the quality and lower the cost of patient care across communities.

“The future of healthcare will rely on the broad and more effective use of data to improve quality and costs, and with this acquisition, Health Catalyst can combine its expertise in data, analytics and decision support, including a data asset of over 100 million patients, with the expertise of Medicity in data exchange across the continuum of care,” said Dan Burton, CEO of Health Catalyst. “Medicity’s experienced team, extensive client roster, expansive data sets, and significant transactional capabilities are a compelling complement to Health Catalyst’s team, capabilities and offerings. Together, we’re well positioned to scale and to offer solutions designed to help our clients apply data-driven insights in a value-based care environment.”

The acquisition combines Medicity’s deep clinical dataset of over 75 million patients and significant transactional capabilities with Health Catalyst’s Data Operating System (DOS™) including AI-driven analytics and business intelligence, and a broad set of financial, cost, patient outcomes, and supply chain data from over 400 hospitals, 4,000 clinics and a data set of over 100 million patients nationwide. The unique combination will empower connected communities with the insights required to improve healthcare outcomes, control costs, and advance population health management.

“The combination of Medicity with Health Catalyst represents the best of both worlds – the transactional capabilities that our customers have been asking for, along with the analytics that Medicity’s customers have sought, delivered now from one company,” said Health Catalyst President Brent Dover, who was president of Medicity before joining Health Catalyst in 2013. “We share complementary technologies, a home base in Salt Lake City, a culture of innovation, and a commitment to improving healthcare. We believe customers of both companies will benefit.”

The integration of Medicity significantly expands the capabilities of the Health Catalyst Data Operating System, which will now have the unique ability to receive and analyze data in real time, and then embed the resulting insights into the workflow of virtually every Electronic Health Record (EHR) on the market today. The combined companies will also have a compelling solution for, and expertise in, the loosely affiliated community ambulatory care management space. These organizations, primarily independent physician groups, are in dire need of a simple means of integrating data between EHRs at the patient encounter level, with enough clinical quality analytics to meet the legal requirements of a Clinically Integrated Network.

“Adding Medicity’s data skills and technology, particularly in physician-led value-based care networks, is a great complement to our solutions,” said Dale Sanders, Health Catalyst’s president of technology. “Both customer bases will benefit from this acquisition. Medicity is very skilled at delivering a high volume of data exchange transactions with high availability. Health Catalyst excels at the bulk movement, curation, and analysis of data, while Medicity has complementary data content that will enhance the precision of our AI algorithms. They have great technology for interacting with literally every EHR under the sun, which will enhance our ability to embed analytics and decision support at the point of care, regardless of who the EHR vendor is.”

Sanders added, “I’ve always been intrigued by the analytics of HIE data traffic; not the data content but rather the network analysis of message types, destinations, and the timing of those messages. We plan on combining that metadata analysis with our data content analysis for new insights into population health, referral patterns, and patient outcomes in a region.  For the promise it offers, I believe this is a good acquisition for the industry.”

About Health Catalyst

Health Catalyst is a next-generation data, analytics, and decision-support company, committed to being a catalyst for massive, sustained improvements in healthcare outcomes. We are the leaders in a new era of advanced predictive analytics for population health and value-based care with a suite of machine learning-driven solutions, decades of outcomes improvement expertise, and an unparalleled ability to unleash and integrate data from across the healthcare ecosystem. Our Health Catalyst Data Operating System (DOS™)—a next-generation data warehouse and application development platform powered by data from more than 100 million patients, and encompassing over 1 trillion facts—helps improve quality, add efficiency and lower costs for organizations ranging from the largest US health system to forward-thinking physician practices. Our technology and professional services can help you keep patients engaged and healthy in their homes, communities, and workplaces, and we can help you optimize care delivery to those patients when it becomes necessary. We are grateful to be recognized by Fortune, Gallup, Glassdoor, Modern Healthcare and a host of others as a Best Place to Work in technology and healthcare. Visit www.healthcatalyst.com, and follow us on TwitterLinkedIn and Facebook. 

July 11, 2018 I Written By

John Lynn is the Founder of the HealthcareScene.com blog network which currently consists of 5 blogs containing over 11,000 articles with John having written over 5500 of the articles himself. These EMR and Healthcare IT related articles have been viewed over 18 million times. John also manages Healthcare IT Central and Healthcare IT Today, the leading career Health IT job board and blog. John is co-founder of InfluentialNetworks.com and Physia.com. John is highly involved in social media, and in addition to his blogs can also be found on Twitter: @techguy and @ehrandhit and LinkedIn.

Hg Invests in Orion Health Rhapsody and Population Health Businesses

BOSTON, Massachusetts – 6 July 2018 – Orion Health Group Limited (NZX:OHE/ASX:OHE) announced that it has reached an agreement in relation to Orion Health’s Rhapsody and Population Health businesses with Hg, a specialist technology investor committed to helping build global businesses with funds of c.£10 billion under management.

The agreement is for entities managed by Hg to acquire majority ownership of Orion Health’s Rhapsody business and to invest in Orion Health’s Population Health business.

Healthcare technology is a core investment area for Hg, having recently completed a number of transactions across the sector. This investment will be made from Hg’s Mercury 2 Fund.

Orion Health built the first Rhapsody integration engine in the late-1990s quickly becoming one of the most recognized interoperability platforms for healthcare organizations today. The combination of Rhapsody’s global team and Hg’s resources will extend Rhapsody as a leader in the interoperability platform space, building on both Rhapsody’s world class technology and highly rated customer service.

Philippe Houssiau, an experienced global technology executive, will step in to lead the Rhapsody business. Philippe has broad experience in leading healthcare businesses, consulting and start-ups, and is formerly CEO of Agfa Healthcare, CEO of Alliance Medical and a Senior Partner with PwC.

“This investment provides Orion Health with a tremendous opportunity to deliver on our vision for customers, our people and for the healthcare sector,” said Ian McCrae, Founder and CEO, Orion Health. “The Board and I believe that Hg is the right partner to accelerate the expansion of Rhapsody and support our vision for our Population Health business.”

“Hg has been researching the theme of interoperability and population health management in healthcare IT over many years,” said David Issott, Partner, Hg. “We believe this is a key global growth theme backed by substantial market funding and resources. Rhapsody provides fantastic products and services for this market and we look forward to partnering with the team at Rhapsody to maximize its potential across the globe. We are also excited to work with Ian and the team to realize the full potential of the Population Health business.”

“Rhapsody is a high-quality business with strong underlying fundamentals and a solid pipeline of new business,” said Philippe Houssiau, CEO Rhapsody. “We believe that the current healthcare market dynamic, with increasing requirement for ‘data liquidity’, presents Rhapsody with a real opportunity for further growth and a solid base for sustained performance. With a focused leadership team and the investment provided by Hg, Rhapsody will be able to leverage its core markets whilst expanding into selected and emerging segments.”

Full details of the transaction can be found in a Market Release on the investor page of Orion Health’s website here. Summary:

–          Hg will acquire Rhapsody for NZ$205 million funded by debt and equity arranged by Hg. Orion Health will then utilize circa NZ$28 million of the transaction proceeds to acquire an ongoing 24.9% shareholding in the Rhapsody business.

–          Hg will also acquire a 24.9% stake in Population Health by investing circa NZ$20 million in that business. Orion Health will invest around NZ$12 million of the Rhapsody transaction proceeds in Population Health based on an agreed enterprise value of NZ$50 million (on a cash free and debt free basis) together with NZ$30 million of net cash to fund ongoing operations.

–          Orion Health will continue to own 100% of its Hospitals business.

–          Following completion of the Hg Transaction, Orion Health will undertake a share buyback offer at an estimated price range of $1.24-$1.29 per share, with the final offer price dependent on Orion Health’s available cash immediately following completion taking into account transaction costs and working capital adjustments in relation to the Rhapsody transaction. Shareholders will have the option to accept the share buyback offer in respect of all or a specified proportion of their Orion Health shares.

–          The bottom of the estimated buy back price range represents a premium of 46% to the closing price per Orion Health share of $0.85 on 2 July 2018 and 55% to the volume weighted average trading price over the last 20 trading days.

The injection of capital will provide investment for Orion Health to build leading global technology for the healthcare sector.

“As the healthcare sector evolves, so too has Orion Health. We believe the biggest advances in healthcare technology will come from a range of capabilities including advanced analytics and better data flow to address critical issues within the sector. In the face of growing and aging populations and the rise of chronic diseases, health systems the world over are under enormous strain. Our Population Health and Hospitals solutions are focused on helping healthcare organizations turn data into insights and clinical action and allow them to use this knowledge to optimize budgets and provide targeted patient care.

“This injection of capital will advance Orion Health’s businesses to reach their full potential over time. For our Population Health business, it will help strengthen our position as a market leader, and for our Hospitals business, it will further support its growth,” said McCrae.

The transaction is subject to a number of conditions, including regulatory approval and the share buyback offer by Orion Health’s shareholders. A notice of meeting describing the Hg Transaction and the share buyback offer will be circulated to shareholders. The independent directors have also commissioned an independent report from KordaMentha.

“This transaction is an important stepping stone in Orion Health’s efforts to build a solid and competitive business and provides our shareholders with choice in relation to their investment,” said Andrew Ferrier, Chairman of the Board, Orion Health. “We believe that providing shareholders both the option to cash-out at a substantial premium to the current trading price and the opportunity to elect to maintain an ongoing investment in Orion Health, including its 24.9% stake in Rhapsody and 75.1% stake in Population Health, is in the best interests of shareholders. This transaction has strong support from Orion Health’s Board and major shareholders.”

About Orion Health
Orion Health (NZX:OHE/ASX:OHE) is a health technology company that provides solutions which enable healthcare to over 110 million patients globally. Its open technology platform, Orion Health Amadeus, seamlessly integrates all forms of relevant data to enable population and personalized healthcare around the world. The company is committed to continual innovation to cement its position at the forefront of precision medicine. For more information visit www.orionhealth.com.

About Hg
Hg is a sector expert investor, committed to helping build ambitious businesses across the technology, services and industrial technology space, primarily in Europe. Deeply resourced sector teams focus on specific sub-sectors and investment themes to identify companies occupying an established position within a niche, and which have the potential to grow faster than their market, create employment and become the leader in their industry. Hg’s dedicated operations innovation team provides practical support to management teams to help them realise their growth ambitions. Based in London and Munich, Hg has funds under management of c. £10 billion serving some of the world’s leading institutional and private investors. For further details, please see www.hgcapital.com

July 9, 2018 I Written By

John Lynn is the Founder of the HealthcareScene.com blog network which currently consists of 5 blogs containing over 11,000 articles with John having written over 5500 of the articles himself. These EMR and Healthcare IT related articles have been viewed over 18 million times. John also manages Healthcare IT Central and Healthcare IT Today, the leading career Health IT job board and blog. John is co-founder of InfluentialNetworks.com and Physia.com. John is highly involved in social media, and in addition to his blogs can also be found on Twitter: @techguy and @ehrandhit and LinkedIn.

AdvancedMD Completes Acquisition of NueMD

AdvancedMD further solidifies position as market-leading cloud platform

July 9, 2018 – South Jordan, Utah-based AdvancedMD, the creator of Rhythm, an end-to-end cloud platform that automates all aspects of clinical and business workflow for independent physician practices and medical billing services, today announced that it has acquired Marietta, Georgia-based Nuesoft Technologies (“NueMD”). The transaction adds to AdvancedMD’s leading market position and extends the feature and functionality both companies will be able to provide practices across the broader ambulatory market.

With over half of independent medical practices still on legacy on-premise software, AdvancedMD continues to benefit from discrete, disconnected workflow moving to a unified end-to-end platform that combines next generation electronic health records and practice management with automated patient engagement applications. By adding NueMD to the AdvancedMD platform, NueMD clients now gain access to a much broader, feature-rich platform with unified clinical and patient engagement solutions. In addition, AdvancedMD clients will benefit from NueMD’s clearinghouse capabilities which further expand upon its unified platform and continue to enhance the value proposition and client experience. With the NueMD acquisition closed, AdvancedMD continues to evaluate further M&A to accelerate its organic growth strategy.

“The acquisition of NueMD is the logical next step for expanding our cloud network of practitioners and physicians who have learned to use end-to-end workflow automation to improve their bottom line and the health of their patients,” said Raul Villar, chief executive officer of AdvancedMD. “NueMD has been a formidable competitor for many years and now we are combining our capabilities to deliver better products and services for all of our clients. We are also extremely excited about adding experienced HCIT experts to the AdvancedMD team and extending our geographic footprint in the Atlanta metro area.”

“We have been on a path similar to AdvancedMD since the beginning,” said Massoud Alibakhsh, CEO and founder of NueMD. “Together, we have tremendous capabilities to disrupt traditional solutions offered to independent physicians, solve the most difficult challenges our practices face and provide them with even better service. AdvancedMD is the category leader and we are excited to be joining forces to become the premier company serving the ambulatory sector with a unified cloud platform built for physicians.”

As a result of the transaction, AdvancedMD’s North American footprint will increase by 27%, expanding the total number of medical practice clients and practitioners to 11,000 and 33,000, respectively. AdvancedMD will retain NueMD offices in Marietta, Georgia.

AdvancedMD is owned by Marlin Equity Partners, a global investment firm with over $6.7 billion of capital under management.

About AdvancedMD

AdvancedMD revolutionized medical office software in 1999 with the introduction of the industry’s first true cloud solution. Today, the company continues to lead MedTech innovation with Rhythm, a complete cloud suite of smart applications that work in unison, accelerating collaborative workflow for every role of the practice. With Rhythm, staff members are empowered to thrive in the online age of healthcare and value-based reimbursement with essential clinicalfinancialpatient engagement and reputation management applications that are unified and available anytime, anywhere on any device. AdvancedMD strives to be the technology heartbeat of healthcare for providers, patients and payers for a healthier world. Visit www.advancedmd.com.

About NueMD

NueMD is a multi-tenant, SaaS platform providing practice management, clinical and medical billing applications to simplify all aspects of running an independent practice.  NueMD clients operate more efficiently and profitably leveraging NueMD’s innovative direct to payer clearinghouse that delivers same day claims processing to practices in nearly all specialties. NueMD also offers medical billing outsourcing services and has 340 medical billing company partners who leverage the NueMD platform to process claims and provide transparency and practice management automation to their clients.

About Marlin Equity Partners

Marlin Equity Partners is a global investment firm with over $6.7 billion of capital under management. The firm is focused on providing corporate parents, shareholders and other stakeholders with tailored solutions that meet their business and liquidity needs. Marlin invests in businesses across multiple industries where its capital base, industry relationships and extensive network of operational resources significantly strengthen a company’s outlook and enhance value. Since its inception, Marlin, through its group of funds and related companies, has successfully completed over 130 acquisitions. The firm is headquartered in Los Angeles, California with an additional office in London. For more information, please visit www.marlinequity.com.

I Written By

John Lynn is the Founder of the HealthcareScene.com blog network which currently consists of 5 blogs containing over 11,000 articles with John having written over 5500 of the articles himself. These EMR and Healthcare IT related articles have been viewed over 18 million times. John also manages Healthcare IT Central and Healthcare IT Today, the leading career Health IT job board and blog. John is co-founder of InfluentialNetworks.com and Physia.com. John is highly involved in social media, and in addition to his blogs can also be found on Twitter: @techguy and @ehrandhit and LinkedIn.

Inspirata Acquires Health Analytics Company, Caradigm; Plans to Use its Award-Winning Platform to Accelerate Development of its Cancer Information Data Trust

Inspirata will continue to evolve Caradigm’s population health management solutions and support existing customers, and has aggressive plans to create new customers in this space.

Redmond, WA, June 13, 2018 (GLOBE NEWSWIRE) — Cancer informatics and digital pathology workflow solution provider Inspirata®, Inc. announced today that it has acquired Redmond, WA-based Caradigm from GE Healthcare.

The company’s award-winning Caradigm Intelligence Platform (CIP) and population health management software portfolio spans data control; healthcare analytics; and care coordination and engagement across the entire healthcare enterprise, including large integrated delivery networks, accountable care organizations, clinically integrated networks, academic medical centers and community hospital networks.

“Caradigm has built a highly regarded, industry-proven big data health analytics platform,” says Inspirata CEO Satish Sanan. “Our goal is to leverage the core strengths of this platform to accelerate our Cancer Information Data Trust (CIDT) development. The CIDT will address key trends in oncology care providing important new insights for clinicians, researchers, drug discovery and cancer center operations. In addition to this, Caradigm’s strong population health product set and experienced team will have Inspirata’s specialized focus and attention to promote long-term sustainability, growth and innovation as we redouble our focus on delivering superior value to all customers.”

“We are confident that Inspirata will be able to provide the intense focus and vision needed for growth through key investments in technology, infrastructure and people to energize the Caradigm software portfolio to better enable us to serve customers’ evolving needs,” says Caradigm President and CEO Neal Singh. “The healthcare ecosystem is in dire need of change. With Inspirata, Caradigm can bring that change for providers and advance the health of the patients they serve.”

Caradigm provides an open and a flexible platform that builds a data foundation to meet the evolving demands of a dynamic healthcare environment. Caradigm Intelligence Platform aggregates data across clinical, social, operational and financial sources from disparate source systems – electronic health records, billing systems, payers, claims, pharmacy systems, labs and HIEs, coupled with the need for timely information at the point of care to address a longstanding challenge for healthcare organizations. Caradigm also provides a suite of applications for improving the patient experience of care, improving the health of populations and reducing the per capita cost of healthcare. Caradigm population health solutions enable providers to deliver the appropriate care to patients through effective coordination and patient engagement, improving outcomes and financial results.

About Inspirata, Inc.

Inspirata®, Inc. provides oncology diagnostics workflow solutions that span digital pathology; diagnostic and predictive assays; and precision medicine. It also offers cancer informatics workflows that, in combination with its natural language processing and artificial intelligence algorithms structures unstructured case files and clinician notes to provide key insights for clinical and operational activities as well as cancer reporting. Inspirata’s flagship solution is its Cancer Information Data Trust (CIDT) that generates a longitudinal view of oncology patients—from diagnosis, through treatments and therapies, to outcomes. The CIDT has extensive applications in clinical decision support, research, education, drug discovery and clinical trials enrollment. Its use will extend to physicians, patients, researchers, pharma and others. For more information, please visit www.inspirata.com or contact info@inspirata.com.

About Caradigm

Until its acquisition by Inspirata today, Caradigm was a GE Healthcare Company offering intelligent healthcare analytics and population health management solutions. Caradigm is dedicated to improving patient care, advancing the health of populations and reducing healthcare costs. Its enterprise software portfolio encompasses all capabilities critical to delivering effective population health management, including data control; healthcare analytics; and care coordination and engagement. Caradigm’s customers include large integrated delivery networks, accountable care organizations, clinically integrated networks, academic medical centers, and community hospital networks. Based in Redmond, WA, Caradigm received the Frost & Sullivan 2017 North American Health IT Value-Based Care Management Product Leadership Award. For more information, visit our website.

June 13, 2018 I Written By

John Lynn is the Founder of the HealthcareScene.com blog network which currently consists of 5 blogs containing over 11,000 articles with John having written over 5500 of the articles himself. These EMR and Healthcare IT related articles have been viewed over 18 million times. John also manages Healthcare IT Central and Healthcare IT Today, the leading career Health IT job board and blog. John is co-founder of InfluentialNetworks.com and Physia.com. John is highly involved in social media, and in addition to his blogs can also be found on Twitter: @techguy and @ehrandhit and LinkedIn.

ResMed to Acquire HEALTHCAREfirst, a Cloud-based Software and Services Provider for Home Health and Hospice Agencies

The acquisition strengthens ResMed’s software-as-a-service (SaaS) solutions for homecare providers

SAN DIEGO – May 29, 2018 – ResMed (NYSE: RMD, ASX: RMD), a global leader in connected healthcare solutions, today announced it has entered into a definitive agreement to acquire privately held HEALTHCAREfirst, a provider of software solutions and services for home health and hospice agencies.

HEALTHCAREfirst offers electronic health record (EHR) software, billing and coding services, and advanced analytics that enable home health and hospice agencies to optimize their clinical, financial and administrative processes. HEALTHCAREfirst will complement ResMed’s existing software solutions offered by Brightree, a wholly owned subsidiary ranked as one of the top 100 healthcare IT companies in the United States.

“The home health and hospice segments are large and growing fast, due to the rising prevalence of chronic conditions and an aging population shifting to homecare and other lower-cost care settings,” said Raj Sodhi, president of ResMed’s SaaS business. “HEALTHCAREfirst’s solutions suite enables ResMed to help efficiently and effectively manage this growing population, benefiting patients, their families, agencies and payers.

“Joining ResMed, with their purpose of changing lives with every breath, is an exciting opportunity for our HEALTHCAREfirst team, as our joint mission is linked to improving quality of life for patients in out-of-hospital healthcare,” said J. Kevin Porter, HEALTHCAREfirst’s president and CEO. “We believe our combined resources and investment capabilities will make an even more impactful improvement on the patient experience and our customers’ business outcomes at a time when they’re under increased reimbursement and regulatory pressures.”

The transaction’s financial terms were not disclosed, but the transaction will not be material to ResMed’s consolidated financial results. The transaction is expected to be finalized before the end of the first quarter of ResMed’s fiscal year 2019 (September 30, 2018), subject to customary closing conditions, including regulatory approvals.

About ResMed

ResMed (NYSE: RMD, ASX: RMD), a world-leading connected health company with more than 5 million cloud-connected devices for daily remote patient monitoring, changes lives with every breath. Its award-winning devices and software solutions help treat and manage sleep apnea, chronic obstructive pulmonary disease and other respiratory conditions. Its 6,000-member team strives to improve patients’ quality of life, reduce the impact of chronic disease and save healthcare costs in more than 120 countries. ResMed.com

About HEALTHCAREfirst 

HEALTHCAREfirst provides cloud-based technologies and services to improve business and clinical operations for thousands home health and hospice providers across the United States. Based in Springfield, MO, and one of the fastest growing providers of its kind, the company provides agency and clinical management software, outsourced revenue cycle management services (billing, coding and OASIS Review), CAHPS surveys, and advanced analytics, in any combination. HEALTHCAREfirst’s breadth of solutions offers agencies a single source to improve patient care, create operational efficiencies, increase profitability and simplify CMS compliance. With HEALTHCAREfirst, agencies can focus on patients instead of paperwork. For more information call 800.841.6095 or visit healthcarefirst.com.

May 29, 2018 I Written By

John Lynn is the Founder of the HealthcareScene.com blog network which currently consists of 5 blogs containing over 11,000 articles with John having written over 5500 of the articles himself. These EMR and Healthcare IT related articles have been viewed over 18 million times. John also manages Healthcare IT Central and Healthcare IT Today, the leading career Health IT job board and blog. John is co-founder of InfluentialNetworks.com and Physia.com. John is highly involved in social media, and in addition to his blogs can also be found on Twitter: @techguy and @ehrandhit and LinkedIn.

HGS Acquires AxisPoint Health

Acquisition to Strengthen HGS’ Healthcare Portfolio with new Capabilities in Clinical Services Segment

Westminster – Colorado, US, April 3, 2018: Hinduja Global Solutions Limited (HGS) (Listed on NSE & BSE, India), has announced that its subsidiary, HGS Population Health LLC, USA, has acquired CMH Services Subsidiary LLC, USA, operating under the trade name of AxisPoint Health, a leading population health management company.

AxisPoint Health offers industry-leading care management, nurse advice line and analytics services, including CarePointGuidePoint and Analytix. The company has around 400 employees including over 280 US registered nurses in the US providing condition and case management programs, a 24/7 nurse advice line, and powerful tools for member identification, stratification and reporting. HGS gains access to over 20 new clients across leading commercial plans, Blues plans and state Medicaid programs.

“The acquisition of AxisPoint Health adds a strategic capability to our healthcare portfolio by strengthening our presence in the clinical services segment, and specifically in the population health management space. Combined with our existing services, we see a huge opportunity to cross-sell solutions to the payer industry,” said Partha DeSarkar, Chief Executive Officer, HGS.

The newly-added portfolio of services opens up addressable market opportunities and provides a more robust value proposition to customers.

Ramesh Gopalan, President – Global Healthcare and Head of India Business, HGS said, “The population health management segment is an attractive market, with healthcare payers looking to simplify and personalize the care experience while reducing costs and improving health outcomes. HGS already has a significant presence in the US healthcare market, and we see a lot of synergies with AxisPoint Health’s portfolio of services.”

HGS’ acquisition of, and new investment in, AxisPoint Health’s services will allow the latter to further strengthen its offerings.

“With the support of a global powerhouse behind us, we’ll have the resources we need to continue to provide our clients with the best, most innovative and most efficient solutions that empower members to make the right choices for their health,” said Christopher A. Long, Chief Executive Officer of AxisPoint Health. “We are excited about the opportunities ahead and remain committed to working closely with our clients to meet their specific business needs.”

About Hinduja Global Solutions (HGS):

A global leader in business process management (BPM) and optimizing the customer experience lifecycle, HGS is helping make its clients more competitive every day. HGS combines technology-powered services in automation, analytics and digital with domain expertise focusing on back office processing, contact centers and HRO solutions to deliver transformational impact to clients. Part of the multi-billion dollar conglomerate Hinduja Group, HGS takes a true “globally local” approach, with over 46,000 employees across 69 delivery centers in seven countries making a difference to some of the world’s leading brands across nine key verticals. For the year ended 31st March 2017, HGS had revenues of Rs. 3,711 crore (US$ 555 million).

Log in to https://www.teamhgs.com/  to know how we can help make you more competitive.

About AxisPoint Health:

AxisPoint Health is a population health management company that combines innovative technology with outstanding care management services to reduce costs, improve outcomes and boost consumer satisfaction – the Triple Aim of healthcare. We make a difference in people’s lives by effectively engaging them to improve their health. Our expert care teams leverage predictive analytics, innovative condition and case management programs, and consumer engagement technology to guide, impact and personalize the care experience. We believe that consumers are people, not just conditions. For more information visit www.axispointhealth.com.

April 3, 2018 I Written By

John Lynn is the Founder of the HealthcareScene.com blog network which currently consists of 5 blogs containing over 11,000 articles with John having written over 5500 of the articles himself. These EMR and Healthcare IT related articles have been viewed over 18 million times. John also manages Healthcare IT Central and Healthcare IT Today, the leading career Health IT job board and blog. John is co-founder of InfluentialNetworks.com and Physia.com. John is highly involved in social media, and in addition to his blogs can also be found on Twitter: @techguy and @ehrandhit and LinkedIn.

Wolters Kluwer Health Completes Acquisition of Firecracker

March 21, 2018 – Wolters Kluwer Health announces today that it has completed the acquisition of Firecracker, as originally announced on March 5, 2018.  See original announcement at the bottom

About Wolters Kluwer
Wolters Kluwer N.V. (AEX: WKL) is a global leader in information, software solutions, and services for professionals in the health, tax and accounting, risk and compliance, finance and legal sectors. We help our customers make critical decisions every day by providing expert solutions that combine deep domain knowledge with specialized technology and services.

Wolters Kluwer reported 2017 annual revenues of €4.4 billion. The company, headquartered in Alphen aan den Rijn, the Netherlands, serves customers in over 180 countries, maintains operations in over 40 countries, and employs 19,000 people worldwide.

Wolters Kluwer shares are listed on Euronext Amsterdam (WKL) and are included in the AEX and Euronext 100 indices. Wolters Kluwer has a sponsored Level 1 American Depositary Receipt program. The ADRs are traded on the over-the-counter market in the U.S. (WTKWY).

For more information about our solutions and organization, visit www.wolterskluwer.com, follow us on TwitterFacebookLinkedIn, and YouTube.

Original Announcement:

Wolters Kluwer Health announces today that it has signed an agreement to acquire Firecracker, an adaptive learning, assessment, and study-planning solution used by more than 20 percent of U.S. medical students.

Firecracker will become part of the Health Learning, Research & Practice group, which produces high quality medical education and practice content under the Lippincott imprint.

Founded in 2009, Firecracker uses a technology- and data-driven approach to improve medical student learning in preparation for high stakes exams, including the United States Medical Licensing Examination (USMLE). The platform, in which more than 85 million questions are answered annually, is powered by an adaptive algorithm that delivers personalized learning and remediation to ensure ongoing retention of content and preparedness for medical school finals and certification exams.

“We’re excited to expand our portfolio of online evidence-based learning tools with Firecracker’s proven technology,” said Diana Nole, CEO, Wolters Kluwer Health. “Combined with Lippincott premium content and solutions, Firecracker enhances our position in the medical education market and helps us further leverage machine learning and advanced technologies to help clinicians deliver the best quality care to patients.”

Firecracker has 16 employees and is headquartered in Boston, Massachusetts. Revenues are recurring in nature and derived from the U.S. market. Wolters Kluwer expects the acquisition to deliver a return on invested capital above its after tax weighted average cost of capital (8%) within three to five years of completion and to have an immaterial impact on adjusted earnings.

Completion of the transaction is subject to customary closing conditions.

March 21, 2018 I Written By

John Lynn is the Founder of the HealthcareScene.com blog network which currently consists of 5 blogs containing over 11,000 articles with John having written over 5500 of the articles himself. These EMR and Healthcare IT related articles have been viewed over 18 million times. John also manages Healthcare IT Central and Healthcare IT Today, the leading career Health IT job board and blog. John is co-founder of InfluentialNetworks.com and Physia.com. John is highly involved in social media, and in addition to his blogs can also be found on Twitter: @techguy and @ehrandhit and LinkedIn.

The SSI Group Announces Acquisition of ICA

Combination of administrative, financial, and clinical information exchange services enhances ability to meet the evolving needs of the healthcare industry

MOBILE, ALMarch 1, 2018The SSI Group, an industry leader in revenue cycle management (RCM) solutions, has announced the acquisition of Informatics Corporation of America (ICA), a leader in the aggregation and exchange of patient clinical data under the brand name of CareAlign.

The combined expertise and information services will help a diverse set of healthcare organizations improve their ability to address the growing need to combine administrative, financial, and clinical data driven by changes in healthcare delivery and payment models. SSI will continue to support the needs of HIEs and other healthcare organizations that need to aggregate and exchange patient clinical data through the CareAlign suite of products. Additionally, SSI will create new solutions derived from the integration of their administrative and clinical data services.

“The integration of the CareAlign solutions into the SSI services platform will provide SSI the ability to expand the breadth of health information exchange services offered to our clients,” said Jimmy Lyons, CEO and President of SSI. “SSI has 30 years of experience in the development and delivery of EDI clearinghouse services to support the information exchange requirements of our revenue cycle clients. The expertise gathered from the operations of this network, which connects thousands of providers and payers daily, can be leveraged to address the growing demand for clinical data exchange.”

Jeff Miller, Chief Product Officer at SSI adds, ”Integrating clinical information with the administrative and financial data used by SSI revenue cycle solutions will be critical in responding to the changes in payment models represented by value-based reimbursement programs like MACRA.” As these models evolve, healthcare business leaders will demand solutions that can provide a more holistic view of the operational aspects impacting revenue performance.

Ben Rooks, Managing Principal of ST Advisors observed, “SSI’s been a client since 2017 and we have discussed how to grow its breadth of services. Health networks sponsored by HIEs, provider communities, and health plans can meaningfully improve patient care while lowering the costs to deliver it. This expansion into clinical data will provide SSI clients with a complete view of their patients, marrying the clinical and financial.”

ICA was headquartered in Nashville, TN, and SSI has decided to keep the office and establish a local presence. “With the concentration of healthcare in the Nashville area, it was always in our plans to open a regional office there. We look forward to growing the office and establishing a presence in Nashville,” added Mr. Lyons.

SSI will be attending the HIMSS18 annual conference, March 5-9 in Las Vegas, Nevada, at booth #1929. For more information about SSI, visit www.thessigroup.com.

About SSI:

SSI delivers solutions that increase the accuracy and velocity of data exchange among healthcare providers and payers, with the highest levels of security. A privately held company since its founding 30 years ago, SSI is singularly focused on the healthcare industry. SSI’s commitment to our clients’ success is evident with nearly 50% of our clients relying on SSI solutions for 10 years or more. Our revenue cycle, EDI gateway, and clinical data interoperability solutions are among the best in the industry and help our clients effectively and efficiently manage their clinical and claims data. Learn how we can help you at www.thessigroup.com.

March 1, 2018 I Written By

John Lynn is the Founder of the HealthcareScene.com blog network which currently consists of 5 blogs containing over 11,000 articles with John having written over 5500 of the articles himself. These EMR and Healthcare IT related articles have been viewed over 18 million times. John also manages Healthcare IT Central and Healthcare IT Today, the leading career Health IT job board and blog. John is co-founder of InfluentialNetworks.com and Physia.com. John is highly involved in social media, and in addition to his blogs can also be found on Twitter: @techguy and @ehrandhit and LinkedIn.